Clinical efficacy analysis of acupuncture combined with anti-tumor necrosis factor treatment for spleen and kidney yang deficiency type ulcerative colitis - Takeaways - MDSpire

Clinical efficacy analysis of acupuncture combined with anti-tumor necrosis factor treatment for spleen and kidney yang deficiency type ulcerative colitis

  • By

  • Pengfei Qin

  • Yunchun Luo

  • Yuzhou Yao

  • Ni Zhu

  • Wen Yi

  • July 1, 2026

  • 0 min

Share

  • 1

    This study evaluates the effectiveness of acupuncture combined with anti-TNF therapy for ulcerative colitis associated with spleen-kidney yang deficiency.

  • 2

    A total of 90 patients were analyzed, with 42 receiving acupuncture alongside TNF-α inhibitors and 48 receiving only the inhibitors.

  • 3

    After 12 weeks, the study group showed significantly lower Mayo and TCM syndrome scores compared to baseline measurements.

  • 4

    The colectomy rate was lower in the study group at 7.14% compared to 20.8% in the control group, indicating a potential benefit of acupuncture.

  • 5

    No severe adverse reactions were reported in either group, and the incidence of adverse events was similar between the two treatment approaches.

Original Source(s)

Clinical efficacy analysis of acupuncture combined with anti-tumor necrosis factor treatment for spleen and kidney yang deficiency type ulcerative colitis

  • by Pengfei Qin, Yunchun Luo, Yuzhou Yao, Ni Zhu, Wen Yi

  • July 1, 2026

Related Content

Congenital aerodigestive fistula with extraordinarily delayed adult presentation: a case report and review of endoscopic closure for bronchoesophageal fistula

Radiomics-Based AI for the Diagnosis and Prognosis of Vessels Encapsulating Tumor Clusters in Hepatocellular Carcinoma: Systematic Review and Meta-Analysis

Application of three-dimensional visualization technology on one-step PTCSL for complex hepatolithiasis